Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
June 23rd, 2023
3.6K views
This article details simultaneous electroencephalogram and functional magnetic resonance imaging (EEG-fMRI) recording procedures that can be used in both clinical and research settings. EEG processing procedures to remove imaging artifacts for clinical review are also included. This study focuses on the example of epilepsy during the interictal period.
Overview
This article presents a detailed protocol for simultaneous electroencephalogram and functional magnetic resonance imaging (EEG-fMRI) recordings, applicable in both clinical and research environments. The focus is on epilepsy during the interictal period, highlighting EEG processing procedures to eliminate imaging artifacts.
Key Study Components
Area of Science
- Neuroscience
- Clinical Research
- Imaging Techniques
Background
- Simultaneous EEG-fMRI enhances understanding of seizure onset.
- It aids in localizing epileptic events.
- This technique is crucial for patients with medication-refractory epilepsy.
- Up to one-third of epilepsy patients may benefit from this approach.
Purpose of Study
- To establish a standardized EEG-fMRI recording protocol.
- To improve artifact removal for accurate clinical review.
- To facilitate neurosurgical planning for epilepsy treatment.
Methods Used
- Marking electrode positions on the scalp using the 10-20 system.
- Applying conductive paste and securing electrodes with glue.
- Connecting EEG equipment to the MRI scanner for synchronized recording.
- Implementing artifact correction procedures during EEG analysis.
Main Results
- Successful setup of EEG-fMRI recording protocol.
- Effective removal of MR artifacts from EEG signals.
- Improved accuracy in mapping epileptic activity.
- Enhanced guidance for neurosurgical interventions.
Conclusions
- The EEG-fMRI protocol is viable for clinical and research applications.
- Artifact correction is essential for reliable EEG data.
- This approach can significantly benefit epilepsy management.
Frequently Asked Questions
What is EEG-fMRI?
EEG-fMRI is a technique that combines electroencephalography and functional magnetic resonance imaging to study brain activity.
How does this protocol help epilepsy patients?
It helps in localizing seizure onset and guiding neurosurgical treatment for patients who do not respond to medication.
What are the key steps in setting up EEG-fMRI?
Key steps include marking electrode positions, applying conductive paste, and connecting EEG equipment to the MRI scanner.
Why is artifact removal important?
Artifact removal is crucial for ensuring the accuracy and reliability of EEG data during analysis.
Can this protocol be used in research?
Yes, the protocol is designed for both clinical and research settings.
What is the significance of the 10-20 system?
The 10-20 system is a standardized method for placing EEG electrodes on the scalp to ensure consistency in recordings.
Executive Industry Relevance
Simultaneous EEG-fMRI with artifact removal enables precise localization of epileptic activity, supporting translational research and clinical review in neurology. This protocol bridges research and clinical workflows, enhancing predictive confidence in seizure onset mapping and supporting risk-adjusted decisions for neurosurgical intervention. The approach strengthens portfolio value by enabling standardized, reproducible data acquisition across discovery and clinical settings.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neural pathways implicated in epilepsy for mechanistic de-risking.
- Supports functional target validation by correlating electrophysiological and hemodynamic signals.
- Facilitates predictive confidence in identifying seizure onset zones for translational research.
Screening & Assay Development
- Prepares validated neurophysiological systems for downstream compound screening or biomarker studies.
- Standardizes artifact removal to ensure reproducibility and quantitative EEG outputs.
- Enables reliable evaluation of interventions targeting epileptic networks.
Translational & Preclinical Research
- Aligns with disease-relevant systems by capturing interictal and potential postictal brain activity.
- Provides continuity from discovery through preclinical validation by supporting both EMU and MRI workflows.
- De-risks translational advancement by ensuring artifact-free, clinically reviewable data.
Pipeline & Workflow Integration
This protocol integrates from early discovery through translational research, supporting both hypothesis testing and clinical review in epilepsy.
- Discovery Biology: Facilitates hypothesis testing on seizure localization and neural network involvement.
- Screening: Delivers reproducible, artifact-corrected EEG-fMRI data for quantitative analysis.
- Analytics: Provides synchronized electrophysiological and imaging readouts for robust statistical comparison.
- Translational Research: Bridges EMU and MRI workflows, supporting biomarker alignment and clinical applicability.
- Enterprise Reuse: Offers a standardized protocol adaptable across research and clinical environments.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in epilepsy research.
- Operational Value: Promotes standardization, reproducibility, and scalability of neuroimaging workflows.
- Strategic Value: Informs go/no-go decisions for neuromodulatory or pharmacological interventions.
- Portfolio Impact: Supports risk-adjusted prioritization of epilepsy research and clinical programs.
Implementation Considerations
- Requires expertise in EEG-fMRI setup and artifact correction procedures.
- Needs MR-conditional electrode sets and compatible EEG-fMRI instrumentation.
- Demands cross-team standardization for data acquisition and processing.
- Adaptable to both EMU and MRI environments for flexible deployment.
- Artifact removal is essential for clinical review and translational reliability.
Biopharma FAQs
Why does null hypothesis testing matter for EEG-fMRI target validation?
Null hypothesis testing in EEG-fMRI enables objective assessment of whether observed neural activity patterns are statistically linked to seizure onset, supporting robust target validation in epilepsy research and clinical review.
How does independent variable isolation fit EEG artifact removal workflows?
Isolating imaging artifacts as independent variables during EEG processing ensures that only true neural signals are analyzed, enhancing the reliability of downstream discovery and translational workflows.
What do quantitative dependent variable measurements enable in EEG-fMRI?
Quantitative measurements of EEG and fMRI signals allow precise mapping of epileptic activity, enabling comparison across conditions and supporting data-driven decisions in both research and clinical settings.
Why are replication requirements critical for cross-functional EEG-fMRI teams?
Replication ensures that artifact removal and data acquisition protocols yield consistent results across teams, facilitating collaboration between research and clinical groups and supporting enterprise-wide standardization.
What statistical analysis capabilities are required before EEG-fMRI implementation?
Robust statistical tools are needed to validate artifact correction, assess signal quality, and confirm the significance of observed neural patterns, ensuring reliable integration into discovery and clinical pipelines.
